- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Non-invasive Neuromodulation Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Non-invasive Neuromodulation Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-invasive Neuromodulation Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transcranial Direct Current Stimulation (tDCS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-invasive Neuromodulation Device include Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, and Newronika, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-invasive Neuromodulation Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Non-invasive Neuromodulation Device market are listed below:
Neuroelectrics
Magstim
NeuroCare Group
Soterix Medical
Newronika
Rogue Resolutions
Medtronic
Philips Healthcare
Shenzhen Yingchi Technology
Shenzhen Hanix United
Shanghai Qiankang Medical Care Company
TCT Research
EB Neuro SpA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-invasive Neuromodulation Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-invasive Neuromodulation Device, with price, sales, revenue and global market share of Non-invasive Neuromodulation Device from 2019 to 2022.
Chapter 3, the Non-invasive Neuromodulation Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-invasive Neuromodulation Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-invasive Neuromodulation Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive Neuromodulation Device.
Chapter 13, 14, and 15, to describe Non-invasive Neuromodulation Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Non-invasive Neuromodulation Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-invasive Neuromodulation Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-invasive Neuromodulation Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Non-invasive Neuromodulation Device Market Size & Forecast
1.4.1 Global Non-invasive Neuromodulation Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-invasive Neuromodulation Device Sales in Volume (2017-2028)
1.4.3 Global Non-invasive Neuromodulation Device Price (2017-2028)
1.5 Global Non-invasive Neuromodulation Device Production Capacity Analysis
1.5.1 Global Non-invasive Neuromodulation Device Total Production Capacity (2017-2028)
1.5.2 Global Non-invasive Neuromodulation Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-invasive Neuromodulation Device Market Drivers
1.6.2 Non-invasive Neuromodulation Device Market Restraints
1.6.3 Non-invasive Neuromodulation Device Trends Analysis
2 Manufacturers Profiles
2.1 Neuroelectrics
2.1.1 Neuroelectrics Details
2.1.2 Neuroelectrics Major Business
2.1.3 Neuroelectrics Non-invasive Neuromodulation Device Product and Services
2.1.4 Neuroelectrics Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Magstim
2.2.1 Magstim Details
2.2.2 Magstim Major Business
2.2.3 Magstim Non-invasive Neuromodulation Device Product and Services
2.2.4 Magstim Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 NeuroCare Group
2.3.1 NeuroCare Group Details
2.3.2 NeuroCare Group Major Business
2.3.3 NeuroCare Group Non-invasive Neuromodulation Device Product and Services
2.3.4 NeuroCare Group Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Soterix Medical
2.4.1 Soterix Medical Details
2.4.2 Soterix Medical Major Business
2.4.3 Soterix Medical Non-invasive Neuromodulation Device Product and Services
2.4.4 Soterix Medical Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Newronika
2.5.1 Newronika Details
2.5.2 Newronika Major Business
2.5.3 Newronika Non-invasive Neuromodulation Device Product and Services
2.5.4 Newronika Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Rogue Resolutions
2.6.1 Rogue Resolutions Details
2.6.2 Rogue Resolutions Major Business
2.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Product and Services
2.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Non-invasive Neuromodulation Device Product and Services
2.7.4 Medtronic Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Philips Healthcare
2.8.1 Philips Healthcare Details
2.8.2 Philips Healthcare Major Business
2.8.3 Philips Healthcare Non-invasive Neuromodulation Device Product and Services
2.8.4 Philips Healthcare Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shenzhen Yingchi Technology
2.9.1 Shenzhen Yingchi Technology Details
2.9.2 Shenzhen Yingchi Technology Major Business
2.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product and Services
2.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shenzhen Hanix United
2.10.1 Shenzhen Hanix United Details
2.10.2 Shenzhen Hanix United Major Business
2.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Product and Services
2.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shanghai Qiankang Medical Care Company
2.11.1 Shanghai Qiankang Medical Care Company Details
2.11.2 Shanghai Qiankang Medical Care Company Major Business
2.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product and Services
2.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 TCT Research
2.12.1 TCT Research Details
2.12.2 TCT Research Major Business
2.12.3 TCT Research Non-invasive Neuromodulation Device Product and Services
2.12.4 TCT Research Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 EB Neuro SpA
2.13.1 EB Neuro SpA Details
2.13.2 EB Neuro SpA Major Business
2.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Product and Services
2.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-invasive Neuromodulation Device Breakdown Data by Manufacturer
3.1 Global Non-invasive Neuromodulation Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-invasive Neuromodulation Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-invasive Neuromodulation Device
3.4 Market Concentration Rate
3.4.1 Top 3 Non-invasive Neuromodulation Device Manufacturer Market Share in 2021
3.4.2 Top 6 Non-invasive Neuromodulation Device Manufacturer Market Share in 2021
3.5 Global Non-invasive Neuromodulation Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-invasive Neuromodulation Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-invasive Neuromodulation Device Market Size by Region
4.1.1 Global Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2028)
4.1.2 Global Non-invasive Neuromodulation Device Revenue by Region (2017-2028)
4.2 North America Non-invasive Neuromodulation Device Revenue (2017-2028)
4.3 Europe Non-invasive Neuromodulation Device Revenue (2017-2028)
4.4 Asia-Pacific Non-invasive Neuromodulation Device Revenue (2017-2028)
4.5 South America Non-invasive Neuromodulation Device Revenue (2017-2028)
4.6 Middle East and Africa Non-invasive Neuromodulation Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-invasive Neuromodulation Device Sales in Volume by Type (2017-2028)
5.2 Global Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
5.3 Global Non-invasive Neuromodulation Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-invasive Neuromodulation Device Sales in Volume by Application (2017-2028)
6.2 Global Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
6.3 Global Non-invasive Neuromodulation Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
7.2 North America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
7.3 North America Non-invasive Neuromodulation Device Market Size by Country
7.3.1 North America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
7.3.2 North America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-invasive Neuromodulation Device Sales by Type (2017-2028)
8.2 Europe Non-invasive Neuromodulation Device Sales by Application (2017-2028)
8.3 Europe Non-invasive Neuromodulation Device Market Size by Country
8.3.1 Europe Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2028)
9.2 Asia-Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2028)
9.3 Asia-Pacific Non-invasive Neuromodulation Device Market Size by Region
9.3.1 Asia-Pacific Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
10.2 South America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
10.3 South America Non-invasive Neuromodulation Device Market Size by Country
10.3.1 South America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
10.3.2 South America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-invasive Neuromodulation Device Sales by Type (2017-2028)
11.2 Middle East & Africa Non-invasive Neuromodulation Device Sales by Application (2017-2028)
11.3 Middle East & Africa Non-invasive Neuromodulation Device Market Size by Country
11.3.1 Middle East & Africa Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-invasive Neuromodulation Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-invasive Neuromodulation Device
12.3 Non-invasive Neuromodulation Device Production Process
12.4 Non-invasive Neuromodulation Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-invasive Neuromodulation Device Typical Distributors
13.3 Non-invasive Neuromodulation Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Non-invasive Neuromodulation Device Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-invasive Neuromodulation Device Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Neuroelectrics Basic Information, Manufacturing Base and Competitors
Table 4. Neuroelectrics Major Business
Table 5. Neuroelectrics Non-invasive Neuromodulation Device Product and Services
Table 6. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Magstim Basic Information, Manufacturing Base and Competitors
Table 8. Magstim Major Business
Table 9. Magstim Non-invasive Neuromodulation Device Product and Services
Table 10. Magstim Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. NeuroCare Group Basic Information, Manufacturing Base and Competitors
Table 12. NeuroCare Group Major Business
Table 13. NeuroCare Group Non-invasive Neuromodulation Device Product and Services
Table 14. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Soterix Medical Basic Information, Manufacturing Base and Competitors
Table 16. Soterix Medical Major Business
Table 17. Soterix Medical Non-invasive Neuromodulation Device Product and Services
Table 18. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Newronika Basic Information, Manufacturing Base and Competitors
Table 20. Newronika Major Business
Table 21. Newronika Non-invasive Neuromodulation Device Product and Services
Table 22. Newronika Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Rogue Resolutions Basic Information, Manufacturing Base and Competitors
Table 24. Rogue Resolutions Major Business
Table 25. Rogue Resolutions Non-invasive Neuromodulation Device Product and Services
Table 26. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Medtronic Basic Information, Manufacturing Base and Competitors
Table 28. Medtronic Major Business
Table 29. Medtronic Non-invasive Neuromodulation Device Product and Services
Table 30. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. Philips Healthcare Major Business
Table 33. Philips Healthcare Non-invasive Neuromodulation Device Product and Services
Table 34. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Shenzhen Yingchi Technology Basic Information, Manufacturing Base and Competitors
Table 36. Shenzhen Yingchi Technology Major Business
Table 37. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product and Services
Table 38. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Shenzhen Hanix United Basic Information, Manufacturing Base and Competitors
Table 40. Shenzhen Hanix United Major Business
Table 41. Shenzhen Hanix United Non-invasive Neuromodulation Device Product and Services
Table 42. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shanghai Qiankang Medical Care Company Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Qiankang Medical Care Company Major Business
Table 45. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product and Services
Table 46. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. TCT Research Basic Information, Manufacturing Base and Competitors
Table 48. TCT Research Major Business
Table 49. TCT Research Non-invasive Neuromodulation Device Product and Services
Table 50. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. EB Neuro SpA Basic Information, Manufacturing Base and Competitors
Table 52. EB Neuro SpA Major Business
Table 53. EB Neuro SpA Non-invasive Neuromodulation Device Product and Services
Table 54. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Non-invasive Neuromodulation Device Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Non-invasive Neuromodulation Device Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Non-invasive Neuromodulation Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Non-invasive Neuromodulation Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Non-invasive Neuromodulation Device Production Site of Key Manufacturer
Table 60. Non-invasive Neuromodulation Device New Entrant and Capacity Expansion Plans
Table 61. Non-invasive Neuromodulation Device Mergers & Acquisitions in the Past Five Years
Table 62. Global Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 63. Global Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)
Table 64. Global Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 67. Global Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 68. Global Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Non-invasive Neuromodulation Device Price by Type (2017-2022) & (US$/Unit)
Table 71. Global Non-invasive Neuromodulation Device Price by Type (2023-2028) & (US$/Unit)
Table 72. Global Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 73. Global Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 74. Global Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Non-invasive Neuromodulation Device Price by Application (2017-2022) & (US$/Unit)
Table 77. Global Non-invasive Neuromodulation Device Price by Application (2023-2028) & (US$/Unit)
Table 78. North America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 79. North America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 80. North America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 83. North America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 84. North America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 85. North America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 86. Europe Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 87. Europe Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 88. Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 91. Europe Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 92. Europe Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 93. Europe Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 102. South America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 103. South America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 104. South America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 107. South America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 108. South America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 109. South America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 118. Non-invasive Neuromodulation Device Raw Material
Table 119. Key Manufacturers of Non-invasive Neuromodulation Device Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Non-invasive Neuromodulation Device Typical Distributors
Table 123. Non-invasive Neuromodulation Device Typical Customers
List of Figures
Figure 1. Non-invasive Neuromodulation Device Picture
Figure 2. Global Non-invasive Neuromodulation Device Revenue Market Share by Type in 2021
Figure 3. Transcranial Direct Current Stimulation (tDCS)
Figure 4. Transcranial Alternating Current Stimulation (tACS)
Figure 5. Transcranial Pulsed Current Stimulation (tPCS)
Figure 6. Transcranial Random Noise Stimulation (tRNS)
Figure 7. Electroconvulsive therapy (ECT)
Figure 8. Others
Figure 9. Global Non-invasive Neuromodulation Device Revenue Market Share by Application in 2021
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Non-invasive Neuromodulation Device Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Non-invasive Neuromodulation Device Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Non-invasive Neuromodulation Device Sales (2017-2028) & (K Units)
Figure 16. Global Non-invasive Neuromodulation Device Price (2017-2028) & (US$/Unit)
Figure 17. Global Non-invasive Neuromodulation Device Production Capacity (2017-2028) & (K Units)
Figure 18. Global Non-invasive Neuromodulation Device Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Non-invasive Neuromodulation Device Market Drivers
Figure 20. Non-invasive Neuromodulation Device Market Restraints
Figure 21. Non-invasive Neuromodulation Device Market Trends
Figure 22. Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturer in 2021
Figure 23. Global Non-invasive Neuromodulation Device Revenue Market Share by Manufacturer in 2021
Figure 24. Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Non-invasive Neuromodulation Device Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Non-invasive Neuromodulation Device Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2028)
Figure 28. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2017-2028)
Figure 29. North America Non-invasive Neuromodulation Device Revenue (2017-2028) & (USD Million)
Figure 30. Europe Non-invasive Neuromodulation Device Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Non-invasive Neuromodulation Device Revenue (2017-2028) & (USD Million)
Figure 32. South America Non-invasive Neuromodulation Device Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Non-invasive Neuromodulation Device Revenue (2017-2028) & (USD Million)
Figure 34. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 35. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 36. Global Non-invasive Neuromodulation Device Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 38. Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 39. Global Non-invasive Neuromodulation Device Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 41. North America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 42. North America Non-invasive Neuromodulation Device Sales Market Share by Country (2017-2028)
Figure 43. North America Non-invasive Neuromodulation Device Revenue Market Share by Country (2017-2028)
Figure 44. United States Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 48. Europe Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 49. Europe Non-invasive Neuromodulation Device Sales Market Share by Country (2017-2028)
Figure 50. Europe Non-invasive Neuromodulation Device Revenue Market Share by Country (2017-2028)
Figure 51. Germany Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Non-invasive Neuromodulation Device Revenue Market Share by Region (2017-2028)
Figure 60. China Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 67. South America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 68. South America Non-invasive Neuromodulation Device Sales Market Share by Country (2017-2028)
Figure 69. South America Non-invasive Neuromodulation Device Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Non-invasive Neuromodulation Device Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Non-invasive Neuromodulation Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Non-invasive Neuromodulation Device in 2021
Figure 81. Manufacturing Process Analysis of Non-invasive Neuromodulation Device
Figure 82. Non-invasive Neuromodulation Device Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
